Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 7, 2012, Pages 707-716

  Jeong, Imju ^a   Yoon, Shin Hee ^a   Hahn, Sang June ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Dapoxetine; Kv1.5channel; Pulmonary arterial hypertension; Selective serotonin reuptake inhibitor

Indexed keywords

DAPOXETINE; POTASSIUM CHANNEL KV1.5;

ANIMAL CELL; ARTICLE; CHO CELL; CLONE; CONCENTRATION RESPONSE; CONFORMATION; CONTROLLED STUDY; DEPOLARIZATION; DISSOCIATION CONSTANT; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; HYPERPOLARIZATION; IC 50; KINETICS; MEMBRANE POTENTIAL; NONHUMAN; PATCH CLAMP; PROTEIN EXPRESSION; STEADY STATE; TIME;

ANIMALS; BENZYLAMINES; CHO CELLS; CRICETINAE; CRICETULUS; KV1.5 POTASSIUM CHANNEL; NAPHTHALENES; POTASSIUM CHANNEL BLOCKERS; SEROTONIN UPTAKE INHIBITORS;

EID: 84862865229     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0754-y     Document Type: Article

References (49)

1. + channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res 95:308-318 (Pubitemid 39056292)
2. Belik J (2008) Fetal and neonatal effects of maternal drug treatment for depression. Semin Perinatol 32:350-354
3. Brendel J, Peukert S (2003) Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias. Curr Med Chem Cardiovasc Hematol Agents 1:273-287
4. Brown J, PM OB, Marjoribanks J, Wyatt K (2009) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev: CD001396
5. Caballero R, Gomez R, Moreno I, Nunez L, Gonzalez T, Arias C, Guizy M, Valenzuela C, Tamargo J, Delpon E (2004) Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current. Cardiovasc Res 62:86-95 (Pubitemid 38326814)
6. Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS (1999) Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther 291:1-6 (Pubitemid 29451565)
7. Choi BH, Choi JS, Jeong SW, Hahn SJ, Yoon SH, Jo YH, Kim MS (2000) Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 293:634-640 (Pubitemid 30244117)
8. Choi BH, Choi JS, Yoon SH, Rhie DJ, Min DS, Jo YH, Kim MS, Hahn SJ (2001) Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1. Neuropharmacology 41:443-453 (Pubitemid 32816899)
9. + channels Kv1.4. Neuroreport 14:2451-2455
10. Claassen V, Davies JE, Hertting G, Placheta P (1977) Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol 60:505-516 (Pubitemid 8149535)
11. Davies AR, Kozlowski RZ (2001) Kv channel subunit expression in rat pulmonary arteries. Lung 179:147-161 (Pubitemid 34033111)
12. Deak F, Lasztoczi B, Pacher P, Petheo GL, Valeria K, Spat A (2000) Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology 39:1029-1036 (Pubitemid 30155710)
13. + channel current. Circ Res 73:210-216 (Pubitemid 23173072)
14. + current in canine atrial myocytes. Circ Res 93:744-751 (Pubitemid 37288669)
15. Fuller RW, Wong DT (1990) Serotonin uptake and serotonin uptake inhibition. Ann N Y Acad Sci 600:68-78, discussion 79-80
16. Ks channel: potential antiarrhythmic agents. Curr Med Chem Cardiovasc Hematol Agents 1:243-252
17. Gomez R, Nunez L, Caballero R, Vaquero M, Tamargo J, Delpon E (2005) Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1+min K channels. Br J Pharmacol 146:146-161 (Pubitemid 43086104)
18. Gonzalez T, David M, Moreno C, Macias A, Valenzuela C (2010) Kv1.5-Kvβ interactions: molecular determinants and pharmacological consequences. Mini Rev Med Chem 10:635-642
19. Guignabert C, Raffestin B, Benferhat R, Raoul W, Zadigue P, Rideau D, Hamon M, Adnot S, Eddahibi S (2005) Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation 111:2812-2819 (Pubitemid 40791554)
20. Hellstrom WJ (2009) Emerging treatments for premature ejaculation: focus on dapoxetine. Neuropsychiatr Dis Treat 5:37-46
21. Jeong I, Kim SW, Yoon SH, Hahn SJ (2012) Block of cloned Kv4.3 potassium channels by dapoxetine. Neuropharmacology 62:2260-2265
22. Kallen B, Olausson PO (2008) Maternal use of selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 17:801-806
23. Kawut SM, Horn EM, Berekashvili KK, Lederer DJ, Widlitz AC, Rosenzweig EB, Barst RJ (2006) Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension. Pulm Pharmacol Ther 19:370-374 (Pubitemid 44051959)
24. Keller MB (2000) Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials. J Clin Psychiatry 61:896-908 (Pubitemid 32058003)
25. Kendirci M, Salem E, Hellstrom WJ (2007) Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation. Ther Clin Risk Manag 3:277-289 (Pubitemid 46881455)
26. Kowey PR, Mudumbi RV, Aquilina JW, Dibattiste PM (2011) Cardiovascular safety profile of dapoxetine during the premarketing evaluation. Drugs R D 11:1-11
27. Lee HM, Hahn SJ, Choi BH (2010a) Inhibitory action of fluvoxamine on Kv1.5 currents. Biol Pharm Bull 33:977-982
28. Lee HM, Hahn SJ, Choi BH (2010b) Open channel block of Kv1.5 currents by citalopram. Acta Pharmacol Sin 31:429-435
29. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R (1992) Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256
30. Modi NB, Nath R, Staehr P, Gupta SK, Aquilina JW, Rivas D (2009) Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects. J Clin Pharmacol 49:634-642
31. Moreno I, Caballero R, Gonzalez T, Arias C, Valenzuela C, Iriepa I, Galvez E, Tamargo J, Delpon E (2003) Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization. J Pharmacol Exp Ther 304:862-873 (Pubitemid 36152367)
32. + channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation 13:615-632 (Pubitemid 44696118)
33. + channel from vascular and visceral smooth muscles. Am J Physiol 267:C1231-C1238
34. + channels by antidepressant drugs. J Pharmacol Exp Ther 284:208-214 (Pubitemid 28109548)
35. + channel hKv1.5. J Pharmacol Exp Ther 298:1108-1119 (Pubitemid 32761927)
36. Shah SJ, Gomberg-Maitland M, Thenappan T, Rich S (2009) Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension. Chest 136:694-700
37. Snyders DJ (1999) Structure and function of cardiac potassium channels. Cardiovasc Res 42:377-390 (Pubitemid 29243164)
38. Snyders DJ, Yeola SW (1995) Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ Res 77:575-583
39. Snyders DJ, Tamkun MM, Bennett PB (1993) A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression. J Gen Physiol 101:513-543 (Pubitemid 23123420)
40. Standen NB, Quayle JM (1998) K+ channel modulation in arterial smooth muscle. Acta Physiol Scand 164:549-557 (Pubitemid 29015673)
41. Thomas D, Gut B, Wendt-Nordahl G, Kiehn J (2002) The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. J Pharmacol Exp Ther 300:543-548
42. Tytgat J, Maertens C, Daenens P (1997) Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1). Br J Pharmacol 122:1417-1424 (Pubitemid 27503933)
43. + current similar to Kv1.5 cloned channel currents. Circ Res 73:1061-1076 (Pubitemid 23340202)
44. Weir EK, Olschewski A (2006) Role of ion channels in acute and chronic responses of the pulmonary vasculature to hypoxia. Cardiovasc Res 71:630-641 (Pubitemid 44848001)
45. Weir EK, Lopez-Barneo J, Buckler KJ, Archer SL (2005) Acute oxygen-sensing mechanisms. N Engl J Med 353:2042-2055
46. Wong DT, Bymaster FP, Engleman EA (1995) Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 57:411-441
47. Woodhull AM (1973) Ionic blockage of sodium channels in nerve. J Gen Physiol 61:687-708
48. V potassium currents by the antidepressant drug, fluoxetine. Br J Pharmacol 128:1609-1615
49. + channel gene transcription in primary pulmonary hypertension. Lancet 351:726-727 (Pubitemid 28105348)